MHRA
- Status: approved
🇬🇧 Influenza in United Kingdom
NICE has issued 4 UK HTA decisions
Marketing authorisation
Health technology assessment
4 decisions from NICE for Influenza in United Kingdom.
NICE TA732 — — Appraisal terminated
- Indication assessed: treating acute uncomplicated influenza (terminated appraisal)
NICE made a decision to terminate the appraisal of Influenza for treating acute uncomplicated influenza. The decision was made without a recommendation on the cost-effectiveness of the treatment. No restriction or condition was applied to the decision.
NICE TA1135 — — Appraisal terminated
- Indication assessed: treating and preventing influenza in children 1 to 11 years (terminated appraisal)
NICE made a decision to terminate the appraisal of Influenza treatment in children 1 to 11 years. This decision was made without a recommendation on the cost-effectiveness of the treatment. The appraisal was terminated, meaning no further action was taken on the cost-effectiveness of the treatment for this indication.
NICE TA168 — ✗ Not recommended
- Indication assessed: the treatment of influenza
NICE did not recommend the treatment of influenza with this drug. The decision was made for the treatment of influenza. The cost basis of the decision is not reported. There are no restrictions or conditions associated with this decision.
NICE TA158 — ✗ Not recommended
- Indication assessed: the prophylaxis of influenza
NICE made a decision not to recommend the drug for the prophylaxis of influenza. This decision was made without a reported cost-effectiveness analysis, as the ICER was not reported. There were no restrictions or conditions placed on the use of the drug.
Influenza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United Kingdom
Frequently asked questions
Is Influenza approved in United Kingdom?
Yes. MHRA has authorised it.
Who is the marketing authorisation holder for Influenza in United Kingdom?
BioNTech is the originator. The local marketing authorisation holder may differ — check the official source linked above.
Has Influenza been assessed by UK health technology agencies?
Yes — 4 UK HTA decisions on record from NICE.